Vitro Biopharma Inc (DELISTED) (VTRO:DL)
Vitro Biopharma Profit Margin (Quarterly): -151.0% for July 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2023 | -151.0% |
| April 30, 2023 | -459.6% |
| January 31, 2023 | -345.9% |
| October 31, 2022 | -582.1% |
| Date | Value |
|---|---|
| July 31, 2022 | -409.4% |
| April 30, 2022 | -126.9% |
| January 31, 2022 | -31.28% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-582.1%
Minimum
Oct 2022
-31.28%
Maximum
Jan 2022
-300.9%
Average
-345.9%
Median
Jan 2023
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 10.76% |
| Xtant Medical Holdings Inc | -15.79% |
| Asensus Surgical Inc | -2.00K% |
| Senseonics Holdings Inc | -374.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -345.0% |
| Return on Assets | -68.75% |
| Return on Invested Capital | -124.7% |
| Gross Profit Margin (Quarterly) | 83.23% |
| Operating Margin (Quarterly) | -180.1% |
| Return on Net Operating Assets | -87.63% |